Q3 2023 · 13F-HR
DAFNA Capital Management LLCholdings as filed
Filed 2023-11-14 · accession 0001389932-23-000010
$321.5M
Reported value
75
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78464A870 | XBI | SPDR S&P BIOTECH ETF | $41.3M | 12.8% | 565,000 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $21.6M | 6.72% | 13,680,554 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $14.1M | 4.39% | 479,538 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $13.5M | 4.19% | 499,820 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $13.1M | 4.08% | 473,394 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $12.8M | 3.97% | 136,212 | Common | SOLE |
| 464287556 | IBB | ISHARES NASDAQ BIOTECH INDX | $12.5M | 3.90% | 102,500 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $12.5M | 3.90% | 249,521 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $11.4M | 3.56% | 484,870 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $9.6M | 2.98% | 280,538 | Common | SOLE |
| 48576A100 | — | KARUNA THERAPEUTICS INC | $8.9M | 2.78% | 52,873 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $8.3M | 2.58% | 73,615 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $7.2M | 2.24% | 586,463 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $6.7M | 2.07% | 458,373 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $6.3M | 1.96% | 67,552 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $5.8M | 1.81% | 605,532 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $5.7M | 1.76% | 1,447,465 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $5.5M | 1.71% | 125,529 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HOLDING INC | $5.3M | 1.65% | 231,748 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $5.0M | 1.56% | 550,784 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $4.7M | 1.46% | 935,894 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $4.6M | 1.44% | 652,000 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $4.6M | 1.43% | 220,708 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $4.4M | 1.36% | 556,695 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $4.1M | 1.27% | 628,938 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $4.0M | 1.26% | 92,887 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $4.0M | 1.24% | 222,717 | Common | SOLE |
| 04351PAD3 | ASND 2.25 04/01/28 | ASCENDIS PHARMA A/S | $3.7M | 1.15% | 4,000,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $3.5M | 1.10% | 319,655 | Common | SOLE |
| 004397105 | ARAY | ACCURAY INC | $3.3M | 1.03% | 1,222,358 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $3.0M | 0.93% | 519,384 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $2.7M | 0.85% | 257,653 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $2.6M | 0.81% | 1,307,407 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $2.5M | 0.76% | 122,200 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $2.2M | 0.70% | 122,547 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $2.2M | 0.69% | 67,300 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $2.2M | 0.69% | 295,493 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $2.2M | 0.67% | 928,253 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $2.1M | 0.65% | 65,961 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $2.1M | 0.65% | 60,175 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $1.9M | 0.60% | 300,000 | Common | SOLE |
| 10501L106 | BWAY | BRAINSWAY LTD | $1.7M | 0.54% | 432,181 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $1.5M | 0.47% | 1,111,049 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $1.4M | 0.44% | 193,000 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HOLDINGS INC | $1.4M | 0.42% | 62,200 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $1.3M | 0.41% | 83,000 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $1.3M | 0.40% | 327,373 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $1.3M | 0.40% | 570,130 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $1.2M | 0.39% | 962,513 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $1.2M | 0.38% | 1,476,052 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $1.2M | 0.38% | 940,582 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $1.2M | 0.37% | 258,496 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $1.2M | 0.36% | 127,284 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $1.1M | 0.34% | 797,054 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $1.1M | 0.34% | 98,560 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $1.1M | 0.33% | 265,878 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $982,284 | 0.31% | 283,079 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $932,228 | 0.29% | 734,038 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $928,740 | 0.29% | 172,308 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $910,350 | 0.28% | 35,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $863,775 | 0.27% | 22,500 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $734,705 | 0.23% | 76,852 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $538,160 | 0.17% | 28,000 | Common | SOLE |
| 64131A105 | STIM | NEURONETICS INC | $423,518 | 0.13% | 313,717 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $298,170 | 0.09% | 450,000 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $273,830 | 0.09% | 351,064 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $263,040 | 0.08% | 3,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $258,189 | 0.08% | 192,678 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $230,258 | 0.07% | 116,882 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $214,379 | 0.07% | 166,185 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $190,838 | 0.06% | 205,202 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $151,250 | 0.05% | 125,000 | Common | SOLE |
| 49705R105 | KNTEUSD | KINNATE BIOPHARMA INC | $147,251 | 0.05% | 105,179 | Common | SOLE |
| 45780L104 | INGN | INOGEN INC | $78,300 | 0.02% | 15,000 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $74,241 | 0.02% | 7,300 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.